title: Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: A
authors.initials: A
authors.lastname: Choughule
authors.affiliation: 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: R
authors.initials: R
authors.lastname: Sharma
authors.affiliation: 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: V
authors.initials: V
authors.lastname: Trivedi
authors.affiliation: 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: A
authors.initials: A
authors.lastname: Thavamani
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: V
authors.initials: V
authors.lastname: Noronha
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: A
authors.initials: A
authors.lastname: Joshi
authors.affiliation: Department of Pathology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: S
authors.initials: S
authors.lastname: Desai
authors.affiliation: Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: P
authors.initials: P
authors.lastname: Chandrani
authors.affiliation: Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: P
authors.initials: P
authors.lastname: Sundaram
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: S
authors.initials: S
authors.lastname: Utture
authors.affiliation: Department of Pathology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: N
authors.initials: N
authors.lastname: Jambhekar
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: J
authors.initials: J
authors.lastname: Aich
authors.affiliation: Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
authors.forename: K
authors.initials: K
authors.lastname: Prabhash
authors.affiliation: Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
authors.forename: A
authors.initials: A
authors.lastname: Dutt
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000235:genetics*
chemical_list: C117307:KRAS protein, human; D047428:Protein Kinase Inhibitors; D011518:Proto-Oncogene Proteins; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins